What is Retailio?
Retailio operates as India's largest B2B pharma platform, functioning as a comprehensive digital ecosystem that connects the entire pharmaceutical value chain. The platform integrates pharmacies, chemists, wholesalers, and manufacturers into a unified digital interface, facilitating seamless business transactions, inventory management, and payment processing. By providing exclusive deals and real-time visibility, Retailio addresses long-standing inefficiencies in the traditional supply chain, such as stock-outs and opaque pricing models. Its business process management solutions are engineered to drive operational excellence, allowing stakeholders to optimize their procurement cycles and improve overall profitability within the highly regulated pharmaceutical market.
How much funding has Retailio raised?
Retailio has raised a total of $1.3M across 1 funding round:
Other Financing Round
$1.3M
Other Financing Round (2024): $1.3M with participation from Island Capital, East Valley Ventures, The51, and Pelorus Venture Capital
Key Investors in Retailio
Island Capital
Island Capital is a global merchant bank specializing in real estate investments and advisory services, managing approximately $4.6 billion in assets with a focus on operational turnaround and restructuring.
East Valley Ventures
East Valley is a startup accelerator and angel investor group based in Atlantic Canada that provides financial support and mentorship to local entrepreneurs.
The51
The51 is a Canadian-based wealth creation platform focused on mobilizing female capital to invest in talented female entrepreneurs and venture funds.
What's next for Retailio?
With this latest injection of capital, Retailio is well-positioned to accelerate its digital transformation initiatives and deepen its penetration into tier-two and tier-three markets. The strategic focus will likely shift toward enhancing the platform's predictive analytics capabilities, which will allow for more accurate demand forecasting and inventory optimization for its network of stockists and retailers. Furthermore, the company is expected to leverage these funds to strengthen its fintech offerings, potentially introducing more sophisticated credit and financing tools for small-scale chemists. As the firm scales, maintaining its competitive edge will require continued investment in robust logistics integration and the expansion of its manufacturer-direct partnership programs, ensuring that Retailio remains the primary digital gateway for the Indian pharmaceutical industry.
See full Retailio company page
